Related Experiment Video
Updated: Jul 3, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
[Pharmacogenetics in oncology].
Dominica Morán González1, Silvia Jiménez Cabrera, Alfonso Domínguez-Gil Hurlé
1Servicio de Farmacia, Hospital Universitario de Salamanca, Salamanca, España. dmorang@usal.es
Medicina Clinica
|August 5, 2008
Summary
Pharmacogenetics uses genetic information to predict how individuals will respond to cancer drugs. This allows for personalized medicine, optimizing drug selection and dosage for better treatment outcomes and reduced toxicity.
Area of Science:
- Pharmacogenetics
- Cancer Chemotherapy
- Genomics
Context:
- Advances in understanding genetic polymorphisms affecting drug metabolism and targets in cancer chemotherapy.
- Development of genetic tests and chips for routine clinical application.
- FDA approval of genetic tests for predicting drug toxicity.
Purpose:
- To review the clinical impact of genetic polymorphisms on cancer chemotherapy.
- To highlight the role of pharmacogenetics in predicting drug efficacy and toxicity.
- To support the move towards individualized cancer therapy.
Summary:
- Pharmacogenetics links genetic variations to drug responses, crucial for cancer treatment.
- Genetic profiling aids in selecting optimal drugs and doses, minimizing severe toxicity.
- Specific examples include tests for irinotecan toxicity and CYP450 genotyping.
Impact:
- Enables patient stratification based on genotype to identify those likely to benefit from or experience toxicity with specific treatments.
- Facilitates the selection of the most appropriate medication and optimal dosage for individual patients.
- Moves cancer treatment closer to the goal of true individualized therapy.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...